National Peroxide Ltd is Rated Hold

Rating Overview and Context

On 03 August 2026, National Peroxide Ltd’s rating was revised from 'Sell' to 'Hold' by MarketsMOJO, reflecting a significant improvement in its overall Mojo Score, which rose by 23 points from 40 to 63. This shift indicates a more balanced outlook on the stock, suggesting that while it may not be a strong buy, it is no longer considered a sell. The 'Hold' rating implies that investors should maintain their current positions and monitor the stock closely for further developments.

Here’s How the Stock Looks Today

As of 20 August 2026, National Peroxide Ltd exhibits a mixed but cautiously optimistic profile across key investment parameters. The company operates within the Commodity Chemicals sector and is classified as a microcap, which often entails higher volatility but also potential for growth. The current Mojo Score of 63.0 and the 'Hold' grade reflect a moderate level of confidence in the stock’s prospects.

Quality Assessment

The quality grade for National Peroxide Ltd is below average, signalling some concerns regarding its long-term fundamental strength. The company has experienced a negative compound annual growth rate (CAGR) of -1.79% in operating profits over the past five years, indicating challenges in sustaining profitability growth. Additionally, the average Return on Equity (ROE) stands at a modest 2.75%, which suggests limited efficiency in generating profits from shareholders’ funds. These factors highlight that while the company is operationally stable, it faces hurdles in delivering robust and consistent earnings growth.

Valuation Perspective

Despite the quality concerns, the valuation grade is attractive. Currently, National Peroxide Ltd trades at a Price to Book (P/B) ratio of approximately 1, which is considered reasonable and indicates that the stock is fairly valued relative to its net asset base. The company’s ROE has improved to 5.1%, supporting this valuation. Furthermore, the stock is trading at a discount compared to its peers’ historical valuations, making it an appealing option for value-oriented investors. The PEG ratio of 0.1 underscores the stock’s low price relative to its earnings growth, which has been substantial recently.

Financial Trend and Recent Performance

The financial grade is very positive, reflecting strong recent performance and improving fundamentals. As of 20 August 2026, National Peroxide Ltd has demonstrated significant growth in net sales, with a 12.13% increase reported in the latest quarter. The company has declared positive results for three consecutive quarters, underscoring a trend of operational improvement. Profit Before Tax (PBT) excluding other income for the quarter reached ₹6.70 crores, growing by an impressive 196.5% compared to the previous four-quarter average. Similarly, Profit After Tax (PAT) for the quarter stood at ₹6.61 crores, marking a 104.6% increase over the same period. Net sales for the quarter hit a record high of ₹96.07 crores, signalling strong demand and operational efficiency.

Stock returns have also been encouraging. Over the past six months, the stock has surged by 51.56%, while the year-to-date (YTD) return is 35.04%. The one-year return stands at 2.23%, reflecting some volatility but overall positive momentum. These figures indicate that the company is gaining traction in the market, supported by improving financial results and investor sentiment.

Technical Outlook

The technical grade is bullish, suggesting that the stock’s price action and chart patterns are favourable. Despite a minor one-day decline of 1.01% and a one-week drop of 1.66%, the stock’s one-month gain of 7.10% and three-month gain of 5.69% demonstrate resilience and upward momentum. This technical strength supports the 'Hold' rating, as it indicates potential for further gains while cautioning investors to watch for short-term fluctuations.

Shareholding and Market Capitalisation

National Peroxide Ltd is a microcap company with majority shareholding held by promoters. This concentrated ownership can provide stability and alignment of interests but may also limit liquidity. Investors should consider this factor when evaluating the stock’s risk profile.

What the Hold Rating Means for Investors

The 'Hold' rating on National Peroxide Ltd suggests that investors should maintain their current positions rather than buying more shares or selling existing holdings. This recommendation reflects a balanced view of the company’s prospects: while there are clear signs of operational improvement and attractive valuation, some fundamental weaknesses and market volatility remain. Investors are advised to monitor the company’s quarterly results and market developments closely, as further improvements in quality and financial trends could warrant a more positive outlook in the future.

In summary, National Peroxide Ltd presents a nuanced investment case. Its recent financial performance and valuation metrics offer promise, but the below-average quality grade and modest long-term growth require cautious optimism. The bullish technical indicators add a layer of confidence, making the stock suitable for investors seeking exposure to the commodity chemicals sector with a moderate risk appetite.

Key Metrics at a Glance (As of 20 August 2026)

- Mojo Score: 63.0 (Hold)
- Operating Profit CAGR (5 years): -1.79%
- Average ROE: 2.75% (improved to 5.1%)
- Net Sales Growth (Latest Quarter): 12.13%
- PBT (Quarterly): ₹6.70 crores (+196.5%)
- PAT (Quarterly): ₹6.61 crores (+104.6%)
- Price to Book Value: ~1
- PEG Ratio: 0.1
- Stock Returns: 1Y +2.23%, 6M +51.56%, YTD +35.04%

Investors should weigh these factors carefully when considering National Peroxide Ltd as part of their portfolio, recognising the potential for growth alongside inherent risks.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today